Exact Sciences (EXAS) Revenue & Revenue Breakdown
Exact Sciences Revenue Highlights
Latest Revenue (Y)
$2.50B
Latest Revenue (Q)
$699.26M
Main Segment (Y)
Service
Main Geography (Y)
UNITED STATES
Exact Sciences Revenue by Period
Exact Sciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.50B | 19.93% |
| 2022-12-31 | $2.08B | 17.95% |
| 2021-12-31 | $1.77B | 18.49% |
| 2020-12-31 | $1.49B | 70.19% |
| 2019-12-31 | $876.29M | 92.82% |
| 2018-12-31 | $454.46M | 70.86% |
| 2017-12-31 | $265.99M | 167.66% |
| 2016-12-31 | $99.38M | 151.99% |
| 2015-12-31 | $39.44M | 2093.38% |
| 2014-12-31 | $1.80M | -56.61% |
| 2013-12-31 | $4.14M | - |
| 2012-12-31 | $4.14M | -0.46% |
| 2011-12-31 | $4.16M | -22.10% |
| 2010-12-31 | $5.34M | 12.32% |
| 2009-12-31 | $4.76M | -648.79% |
| 2008-12-31 | $-867.00K | -129.54% |
| 2007-12-31 | $2.94M | -38.21% |
| 2006-12-31 | $4.75M | 11.76% |
| 2005-12-31 | $4.25M | -13.88% |
| 2004-12-31 | $4.93M | 70.11% |
| 2003-12-31 | $2.90M | 223.41% |
| 2002-12-31 | $897.00K | 1663.32% |
| 2001-12-31 | $50.87K | 5086900.00% |
| 2000-12-31 | $1.00 | 100.00% |
| 1999-12-31 | - | 100.00% |
| 1998-12-31 | - | - |
Exact Sciences generated $2.50B in revenue during NA 2023, up 19.93% compared to the previous quarter, and up 550.05% compared to the same period a year ago.
Exact Sciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $699.26M | 9.68% |
| 2024-03-31 | $637.52M | -1.45% |
| 2023-12-31 | $646.88M | 2.95% |
| 2023-09-30 | $628.34M | 1.00% |
| 2023-06-30 | $622.09M | 3.26% |
| 2023-03-31 | $602.45M | 8.94% |
| 2022-12-31 | $553.00M | 5.72% |
| 2022-09-30 | $523.07M | 0.27% |
| 2022-06-30 | $521.64M | 7.21% |
| 2022-03-31 | $486.57M | 2.69% |
| 2021-12-31 | $473.81M | 3.82% |
| 2021-09-30 | $456.38M | 4.96% |
| 2021-06-30 | $434.82M | 8.14% |
| 2021-03-31 | $402.08M | -13.78% |
| 2020-12-31 | $466.34M | 14.20% |
| 2020-09-30 | $408.36M | 51.88% |
| 2020-06-30 | $268.87M | -22.70% |
| 2020-03-31 | $347.82M | 17.68% |
| 2019-12-31 | $295.57M | 35.09% |
| 2019-09-30 | $218.81M | 9.47% |
| 2019-06-30 | $199.87M | 23.34% |
| 2019-03-31 | $162.04M | 13.33% |
| 2018-12-31 | $142.98M | 20.87% |
| 2018-09-30 | $118.29M | 14.96% |
| 2018-06-30 | $102.89M | 13.95% |
| 2018-03-31 | $90.30M | 3.31% |
| 2017-12-31 | $87.41M | 20.44% |
| 2017-09-30 | $72.57M | 25.90% |
| 2017-06-30 | $57.65M | 19.19% |
| 2017-03-31 | $48.36M | 37.24% |
| 2016-12-31 | $35.24M | 25.35% |
| 2016-09-30 | $28.11M | 32.71% |
| 2016-06-30 | $21.18M | 42.80% |
| 2016-03-31 | $14.84M | 17.44% |
| 2015-09-30 | $12.63M | 55.59% |
| 2015-06-30 | $8.12M | 90.32% |
| 2015-03-31 | $4.27M | 183.64% |
| 2014-12-31 | $1.50M | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | -100.00% |
| 2014-03-31 | $294.00K | -71.62% |
| 2013-12-31 | $1.04M | - |
| 2013-09-30 | $1.04M | - |
| 2013-06-30 | $1.04M | - |
| 2013-03-31 | $1.04M | - |
| 2012-12-31 | $1.04M | - |
| 2012-09-30 | $1.04M | - |
| 2012-06-30 | $1.04M | - |
| 2012-03-31 | $1.04M | -0.58% |
| 2011-12-31 | $1.04M | 0.29% |
| 2011-09-30 | $1.04M | -0.29% |
| 2011-06-30 | $1.04M | 0.19% |
| 2011-03-31 | $1.04M | -24.36% |
| 2010-12-31 | $1.38M | 1.40% |
| 2010-09-30 | $1.36M | 3.20% |
| 2010-06-30 | $1.31M | 1.15% |
| 2010-03-31 | $1.30M | 4.42% |
| 2009-12-31 | $1.24M | -0.96% |
| 2009-09-30 | $1.26M | -0.16% |
| 2009-06-30 | $1.26M | 25.80% |
| 2009-03-31 | $1.00M | -152.74% |
| 2008-12-31 | $-1.90M | -662.61% |
| 2008-09-30 | $337.00K | 100.00% |
| 2008-06-30 | - | -100.00% |
| 2008-03-31 | $51.00K | -90.50% |
| 2007-12-31 | $537.00K | - |
Exact Sciences generated $699.26M in revenue during Q2 2024, up 9.68% compared to the previous quarter, and up 116.07% compared to the same period a year ago.
Exact Sciences Revenue Breakdown
Exact Sciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| International Sales | $117.74M | $109.91M | $77.48M | $11.44M | - |
| Product | $545.46M | $438.65M | $365.47M | $404.33M | $254.43M |
| Service | $743.24M | $569.94M | $409.67M | $368.01M | $184.54M |
| COVID-19 Testing | $58.09M | $143.10M | $235.83M | - | - |
| Product and Service, Other | $136.01M | $53.72M | $39.92M | $37.78M | - |
| Product And Service Other | - | - | - | - | $15.49M |
Exact Sciences's latest annual revenue breakdown by segment (product or service), as of Dec 22: Service (46.44%), Product (34.08%), Product and Service, Other (8.50%), International Sales (7.36%), and COVID-19 Testing (3.63%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 Testing | - | - | $5.96M | - | $2.13M | $3.82M | $6.04M | $10.87M | $13.75M | $27.43M | $47.10M | $30.59M | $33.07M | $32.34M | $99.09M | $102.16M | $34.58M | - | - | - |
| Product and Service, Other | - | - | - | - | $41.02M | $38.43M | $35.99M | $31.47M | $37.46M | $31.09M | $17.38M | $13.04M | $12.40M | $10.89M | $11.56M | $9.77M | $6.67M | $11.92M | - | - |
| Service | - | - | - | - | $245.75M | $233.03M | $211.45M | $188.92M | $181.19M | $161.68M | $150.68M | $151.25M | $140.15M | $127.87M | $129.22M | $106.00M | $65.08M | $109.37M | $99.35M | $88.82M |
| Product | - | - | - | - | $176.02M | $171.73M | $156.09M | $140.37M | $135.25M | $113.75M | $109.61M | $116.09M | $111.39M | $101.56M | $108.88M | $98.85M | $59.58M | $98.16M | $108.62M | $103.57M |
| International Sales | - | - | - | - | $35.59M | $37.27M | $28.20M | $31.53M | $28.34M | $29.44M | $29.78M | $27.23M | $26.85M | $26.06M | $21.26M | $16.24M | $19.02M | $20.94M | - | - |
| Product And Service Other | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $10.84M | $7.48M |
Exact Sciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|
| UNITED STATES | $1.97B | $1.66B | $1.41B | $864.85M |
| Non-US | $117.74M | $109.91M | $77.48M | $11.44M |
Exact Sciences's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (94.35%), and Non-US (5.65%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $652.54M | $592.99M | $2.35B | $589.74M | $586.51M | $565.18M | $491.54M | $493.30M | $457.13M | $429.15M | $407.97M | $376.02M | $445.08M | $392.12M | $249.85M | $326.88M |
| Non-US | $46.72M | $44.53M | $153.28M | $38.60M | $35.59M | $37.27M | $31.53M | $28.34M | $29.44M | $27.23M | $26.85M | $26.06M | $21.26M | $16.24M | $19.02M | $20.94M |
Exact Sciences's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (93.32%), and Non-US (6.68%).
Exact Sciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TMO | Thermo Fisher Scientific | $42.86B | $10.54B |
| DHR | Danaher | $14.03B | $3.43B |
| A | Agilent | $6.83B | $1.58B |
| ILMN | Illumina | $4.50B | $1.08B |
| CRL | Charles River Laboratories | $4.13B | $1.03B |
| EXAS | Exact Sciences | $2.50B | $699.26M |
| NTRA | Natera | $1.08B | $413.35M |
| MYGN | Myriad Genetics | $678.40M | $191.90M |
| GH | Guardant Health | $563.95M | $177.24M |
| CDNA | CareDx | $280.32M | $92.27M |
| TWST | Twist Bioscience | $245.11M | $81.46M |
| CSTL | Castle Biosciences | $219.79M | $87.00M |
EXAS Revenue FAQ
What is Exact Sciences’s yearly revenue?
Exact Sciences's yearly revenue for 2023 was $2.5B, representing an increase of 19.93% compared to 2022. The company's yearly revenue for 2022 was $2.08B, representing an increase of 17.95% compared to 2021. EXAS's yearly revenue for 2021 was $1.77B, representing an increase of 18.49% compared to 2020.
What is Exact Sciences’s quarterly revenue?
Exact Sciences's quarterly revenue for Q2 2024 was $699.26M, a 9.68% increase from the previous quarter (Q1 2024), and a 12.41% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $637.52M, a -1.45% decrease from the previous quarter (Q4 2023), and a 5.82% increase year-over-year (Q1 2023). EXAS's quarterly revenue for Q4 2023 was $646.88M, a 2.95% increase from the previous quarter (Q3 2023), and a 16.98% increase year-over-year (Q4 2022).
What is Exact Sciences’s revenue growth rate?
Exact Sciences's revenue growth rate for the last 3 years (2021-2023) was 41.46%, and for the last 5 years (2019-2023) was 185.27%.
What are Exact Sciences’s revenue streams?
Exact Sciences's revenue streams in c 22 are International Sales, Product, Service, COVID-19 Testing, and Product and Service, Other. International Sales generated $117.74M in revenue, accounting 7.36% of the company's total revenue, up 7.12% year-over-year. Product generated $545.46M in revenue, accounting 34.08% of the company's total revenue, up 24.35% year-over-year. Service generated $743.24M in revenue, accounting 46.44% of the company's total revenue, up 30.41% year-over-year. COVID-19 Testing generated $58.09M in revenue, accounting 3.63% of the company's total revenue, down -59.41% year-over-year. Product and Service, Other generated $136.01M in revenue, accounting 8.50% of the company's total revenue, up 153.19% year-over-year.
What is Exact Sciences’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Exact Sciences was Service. This segment made a revenue of $743.24M, representing 46.44% of the company's total revenue.